MedPath

Increased Liver Stiffness: A Study of Acoustic Radiation Force Impulse (ARFI) Elastography

Completed
Conditions
Liver Fibroses
Interventions
Device: Ultrasound with ARFI (acoustic radiation force impulse)
Device: Ultrasound with backscatter imaging
Registration Number
NCT03382119
Lead Sponsor
University of Michigan
Brief Summary

The goal of this study is to determine if ultrasound tools can be used to detect liver stiffness. Acoustic radiation force impulse (ARFI) elastography and backscatter will be used to see if they can detect liver stiffness in different populations of patients with liver disease.

The study is measuring liver stiffness in pediatric patients aged 2-5 years. Patients either have had a Fontan cardiac surgery or have liver disease.

Ultrasound scanning takes images of the liver and has much lower risks for patients. ARFI elastography and other tools can be used to measure liver stiffness.

Detailed Description

If patients have liver congestion, reversing it could prevent liver fibrosis, which cannot be treated. Liver fibrosis has serious health risks and is associated with a higher chance of developing liver cancer later in life.

Subjects from two patient populations will be enrolled in order to test ultrasound technologies. A total of 30 subjects between 2-5 years of age will be enrolled.

1. 15 children with increased liver stiffness due to the Fontan operation

2. 15 children with increased liver stiffness caused by Biliary Atresia.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Patients aged 2-5 years
  • Children who are scheduled to have a Stage 3 Fontan cardiac operation (arm 1) AND Children who have chronic liver disease caused by biliary atresia (arm 2)
  • Patient must be receiving care at the University of Michigan CS Mott Children's Hospital
  • Parent/guardian must be willing to sign the study consent form
Read More
Exclusion Criteria
  • For arm 1 subjects: pre-existing evidence of chronic liver disease (as defined by chronic elevation (over 4 weeks) of alanine aminotransferase (ALT), aspartate aminotransferase (AST), or conjugated bilirubin to greater than two times the upper limit of normal
  • For arm 1 subjects: evidence of overt liver nodularity by conventional US imaging or evidence of portal vein or hepatic vein thrombosis (clots) by US Doppler exam
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients having Fontan cardiac surgeryUltrasound with backscatter imagingThis group includes pediatric patients, aged 2-5 years, who have had a Fontan operation. This surgery corrects a heart defect found at birth in which the heart has only one ventricle. Patients will have an Ultrasound with ARFI imaging.
Patients having Fontan cardiac surgeryUltrasound with ARFI (acoustic radiation force impulse)This group includes pediatric patients, aged 2-5 years, who have had a Fontan operation. This surgery corrects a heart defect found at birth in which the heart has only one ventricle. Patients will have an Ultrasound with ARFI imaging.
Patients with Liver diseaseUltrasound with ARFI (acoustic radiation force impulse)This group includes pediatric patients, aged 2-5 years, who have chronic liver disease caused by biliary atresia. Patients will have an Ultrasound with ARFI imaging.
Patients with Liver diseaseUltrasound with backscatter imagingThis group includes pediatric patients, aged 2-5 years, who have chronic liver disease caused by biliary atresia. Patients will have an Ultrasound with ARFI imaging.
Primary Outcome Measures
NameTimeMethod
Shear wave speed15 minutes

Shear wave speed is a measure of stiffness of liver tissue expressed in units of m/s

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

C.S. Mott Hospital

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath